Robin Fears, Jos W. M. van der Meer and Volker ter Meulen (2011). Science and Health Policy, The Changing Burden of Infectious Disease in Europe
Abstract
Infectious diseases continue to pose major public health challenges in developed, as well as developing, countries. The European Academies Science Advisory Council aims to integrate multidisciplinary analyses to define priorities for European surveillance of new, growing, or potential threats from antimicrobial resistance, vector-borne disease, and pandemic influenza. There is a concomitant need to apply such knowledge toward the development of improved health care and robust policies. We discuss how translational medicine can bridge these global issues by helping to mobilize resources between academia, industry, health care services, and policy-makers.
Robin Fears, Volker ter Meulen (2011). Health benefits of policies to mitigate climate change. The Lancet vol 377, pp995-996.
EASAC Letter in The Lancet 2011
Fears and ter Meulen (2011). The potential of synthetic biology: a view from the European Academies Science Advisory Council. Nature Reviews Microbiology vol 9, p222.
EASAC Letter in Nature Reviews Microbiology 2011
Fears, van der Meer and ter Meulen (2010). Translational medicine policy issues in infectious disease. Science Translational Medicine vol 2 pp12-15.
EASAC Article Science Translational Medicine 2010
www.sciencetranslationalmedicine.org
Fears, Kaufmann, ter Meulen and Zumla on behalf of the EASAC Working Group (2010). Drug-resistant tuberculosis in the European Union: opportunities and challenges for control. Tuberculosis vol 90 pp 182-187.
EASAC Article in Tuberculosis 2010
www.tuberculosisjournal.com
Fears, Zumla and ter Meulen (2009). European bodies can help to tackle TB worldwide. Nature vol 460 p796.
EASAC Letter in Nature 2009
www.nature.com